Skip to content

GSK

Director, US Real-World Evidence and Health Outcomes – Non Small Cell Lung Cancer (NSCLC)

GSK is hiring a Director, US Real-World Evidence and Health Outcomes – Non Small Cell Lung Cancer (NSCLC) for a remote role open to applicants in United States. Level rates it ; you can apply on GSK.

Level's read on this job

  • Little AI ●○○○ is how Level rates this role: aI is not part of the work.
  • The posting lists this role as remote.
  • Level classifies it as an executive role.
  • Level lists 963 other open roles at GSK.
  • The role was posted in the last few days.

AI in this role

Director, US Real-World Evidence and Health Outcomes – Non Small Cell Lung Cancer (NSCLC)

Office-based: Philadelphia, PA or Durham, NC; travel as required (typically up to ~20%). Reports to: Sr. Director and Head, US RWE/HO Oncology


Role Summary:

The role of Director, US Real-World Evidence & Health Outcomes Research Scientist Hematology-Oncology ensures that each medicine GSK brings to market is supported by scientifically credible, high quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions, and value-based pricing. The role is accountable for developing and delivering components of the US data generation plan (including RWE and economic value evidence), ensuring strategic alignment across key internal stakeholders (US Medical, Commercial/Market Access, Global RWE & HO, Global Medical Affairs, R&D Epidemiology and Clinical Development), and driving high-quality deliverables that inform internal decision-making during product development, pre-launch readiness, and lifecycle planning. This role promises a fast-paced environment supporting a new-to-market product in a dynamic hematology space.

Key Responsibilities:

  • Evidence strategy and planning: Implementation of RWE/HO research by developing evidence generation plan and designing multiple RWE/HO studies, aligned to US medical, payer, and access needs; translate strategy into actionable workplans, timelines, and resourcing proposals. Translate needs for evidence into study concepts in alignment with strategic objectives and vision for the asset, e.g. development of study protocols and proposing innovative and cost-effective ways of developing and executing studies
  • Study leadership (RWE/HEOR): Own day-to-day leadership for assigned real-world evidence and health outcomes studies (e.g., real-world evidence studies, cost-effectiveness/budget impact analyses, burden of illness, treatment patterns, patient-focused outcomes) including design and execution in partnership with internal functions and external vendors.

o Ensure key stakeholders, including TA aligned business leaders, are regularly updated on plans through periodic reporting.

o Develop excellent working relationships with external thought leaders to ensure appropriate methods and research agendas are applied, in

accordance with GSK policies.

  • Cross-functional stakeholder management: Build strong working relationships with internal stakeholder groups across medical, market access, R&D and commercial to ensure strategic alignment and optimal cross-functional collaboration and communication. Lead cross-functional stakeholder meetings to align on evidence generation gaps and priorities.
  • Scientific communication and quality: Draft/review project specifications, protocols, statistical analysis plans, study reports, abstracts, posters, and manuscripts; ensure adherence to SOPs and high scientific/operational quality.
  • Internal decision support: Provide RWE & HO input to internal decision-making during development and commercialization planning (e.g., trial design considerations, data gap assessments, value messages, evidence prioritization and sequencing).
  • External insight generation: Maintain strong alignment with Field Based Payer Medical Teams and other field stakeholders to obtain customer insights; incorporate insights into evidence plans and value communication needs.
  • Vendor and budget management: Manage vendors and contractors for assigned studies, including scope, timelines, budget tracking, and change control; escalate risks/issues proactively.
  • Governance, compliance, and capability building: Complete required training, adhere to company/department SOPs, and contribute to continuous improvement of processes that enable efficient planning, execution, and dissemination of RWE & HO deliverables.

Basic Qualifications:

  • Master’s degree or PhD in health economics and outcomes research, epidemiology, public health, biostatistics, or related discipline.
  • 5+ years’ experience within the pharmaceutical industry or academia related research within US Oncology experience.
  • Designing a publication plan and having a presence of RWE/HO research studies at major clinical congresses
  • Experience managing multiple projects simultaneously (Basic Qualification)
  • Experience in RWE and economic evaluation study designs/methods evidenced by publications and/or contributing to study concept sheets and protocols (including clear research questions, endpoints, data source selection, and bias/confounding mitigation), reviewing/authoring key sections of statistical analysis plans and study reports, and ensuring publication/disclosure readiness in accordance with internal SOPs and external requirements.

Preferred Qualifications:


  • Demonstrated success developing and executing health outcomes research plans and delivering high-quality data generation outputs.
  • Oncology (NSCLC) experience (US or global), including familiarity with evolving standards of care, evidence requirements, and stakeholder needs across disease areas.
  • Masters + ~4–6 years or PhD with 2–4+ years of experience within the pharmaceutical industry and/or managed care, hospital, academic, or healthcare consulting environment, including experience collaborating with field-facing teams (e.g., Field Based Payer Medical, Field Medical) and/or Market Access partners.
  • Experience managing real-world data sources and vendors (e.g., claims, EHR, registries) and translating findings into actionable insights and value messages.
  • Demonstrated ability to influence without authority in a matrix environment, evidenced by aligning cross-functional stakeholders on objectives/trade-offs, documenting decisions, and driving actions to closure.
  • Strong communication and presentation skills, demonstrated by developing and presenting clear, decision-oriented materials (e.g., evidence strategy slides, executive readouts) and summarizing outcomes/next steps for senior audiences.
  • Proven ability to prioritize, pivot, and manage multiple projects simultaneously in a matrix environment.
  • Strategic execution experience, demonstrated by translating evidence strategy into workplans (milestones, timelines, resourcing) and delivering outputs across 1–2 concurrent asset workstreams.
  • Demonstrated project and vendor management experience, including defining scope and success criteria, tracking budgets/timelines, proactively identifying risks/issues, and implementing mitigation plans through change control.
  • Experience contributing to congress strategy and publication planning (abstracts, posters, manuscripts).

#LI-GSK


Skills

Cross-Functional Leadership, Digital Fluency, Enterprise Thinking, Evidence Based Decision Making, Flexible Mindset, High Impact Communication, Launch Excellence, Patient Journey

Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

If you require an accommodation or other assistance to apply for a job at GSK, please contact the appropriate Recruitment Staff by emailing us at - usrecruitment.adjustments@gsk.com

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/

How we rate this

Director, US Real-World Evidence and Health Outcomes – Non Small Cell Lung Cancer (NSCLC) at GSK rates 37 out of 100 for how much of the daily work is AI. That makes it Little AI (AI Level 1 of 4). The level is about AI in the job, not seniority.

Classification

Little AI. AI is not part of the work.

  1. ●●●● Builds AI80 to 100
  2. ●●●○ Works on AI60 to 79
  3. ●●○○ Uses AI40 to 59
  4. ●○○○ Little AI0 to 39

Levels come from how often the tools, models and workflows of the role are named in the posting itself. Read the description and count the AI tools, models and workflows it names.

Get new remote AI jobs by email

One email a week, each job rated for how much AI is in the work. No recruiter spam, unsubscribe in one click.

Free.

Similar roles

Other roles that involve little AI, at other companies.

What kind of AI work fits you?

Answer 12 practical questions in about three minutes. Get a simple profile, the work it points to, and live roles to explore next.

Find my next step

More jobs at GSK

Related searches

Same AI level

Jobs by city